Outcome. (A) Kaplan-Meier estimates of duration of response of patients achieving either CR or PR after 4 cycles of GBV induction. (B-D) Kaplan-Meier estimates of (B) time to treatment failure, (C) PFS, and (D) OS for the entire cohort. (E) Course of patients with confirmed PTCL and at least 12 months without progression from inclusion. CL, confidence limit; CMR, complete metabolic response; DEV, study deviation; Histo, histology; uncl., unclassified; NA, not applicable; NE, nonevaluable; PMR, partial metabolic response; PTD, primary treatment discontinuation, not related to disease progression. ∗Previous autologous transplantation.

Outcome. (A) Kaplan-Meier estimates of duration of response of patients achieving either CR or PR after 4 cycles of GBV induction. (B-D) Kaplan-Meier estimates of (B) time to treatment failure, (C) PFS, and (D) OS for the entire cohort. (E) Course of patients with confirmed PTCL and at least 12 months without progression from inclusion. CL, confidence limit; CMR, complete metabolic response; DEV, study deviation; Histo, histology; uncl., unclassified; NA, not applicable; NE, nonevaluable; PMR, partial metabolic response; PTD, primary treatment discontinuation, not related to disease progression. ∗Previous autologous transplantation.

This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal